Showcases Stock ranks

TherapeuticsMD Inc. (TXMD)
1.39  0.09 (6.92%) 07-02 16:00
Open: 1.35 Pre. Close: 1.3
High: 1.44 Low: 1.33
Volume: 7,170,897 Market Cap: 378M
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.442 - 1.448 1.448 - 1.454
Low: 1.317 - 1.322 1.322 - 1.328
Close: 1.38 - 1.391 1.391 - 1.401
Stock Technical Analysis
Target: Six months: 1.71
One year: 1.96
Support: Support1: 1.11
Support2: 0.92
Resistance: Resistance1: 1.46
Resistance2: 1.68
Pivot: 1.26
Moving Averages: MA(5): 1.26
MA(20): 1.27
MA(100): 1.34
MA(250): 2.20
MACD: MACD(12,26): 0.02
Signal(12,26,9): 0.01
%K %D: %K(14,3): 56.21
%D(3): 34.54
RSI: RSI(14): 58.18
52-Week: High: 4.32
Low: 0.85
Change(%): -45.7
Average Vol(K): 3-Month: 564281
10-Days: 442176
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

TXMD has closed below upper band by 0.9%. Bollinger Bands are 56.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to TXMD's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Sun, 28 Jun 2020
When Will TherapeuticsMD, Inc. (NASDAQ:TXMD) Breakeven? - Yahoo Finance

Thu, 25 Jun 2020
Hedge Funds Are Dumping TherapeuticsMD Inc (TXMD) - Yahoo Finance

Thu, 02 Jul 2020
TherapeuticsMD, Inc. (TXMD) Loss -49.22% in one Year: What’s Next? - The News Heater

Fri, 26 Jun 2020
TherapeuticsMD, Inc. (TXMD) Chart Is Flashing Mixed Signals - The News Heater

Thu, 02 Jul 2020
How Does TherapeuticsMD Inc (TXMD) Stock Compare to Others in Drug Manufacturers - Specialty & Generic? - InvestorsObserver

Fri, 12 Jun 2020
TherapeuticsMD Inc. (TXMD) Soars 12.3% on June 12 -

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug ManufacturersSpecialty & Generic
Shares Out. (M) 271.68
Shares Float (M) 244.70
% Held by Insiders 12.67
% Held by Institutions 71.24
Shares Short (K) 82990
Shares Short Prior Month (K) 82020
Stock Financials
EPS -0.762
Book Value (p.s.) -0.170
Profit Margin
Operating Margin -283.04
Return on Assets (ttm) -45.5
Return on Equity (ttm) -2499.2
Qtrly Rev. Growth 210.4
Gross Profit (p.s.) 0.159
Sales Per Share 0.213
EBITDA (p.s.) -0.595
Qtrly Earnings Growth
Operating Cash Flow (M) -166.65
Levered Free Cash Flow (M) -121.91
Stock Valuation
PE Ratio -1.82
PEG Ratio
Price to Book value -8.18
Price to Sales 6.52
Price to Cash Flow -2.27
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator